Zobrazeno 1 - 10 of 39 pro vyhledávání: '"Cabaillé, M."'
2
Akademický článek
Radiothérapie adaptative des cancers de la vessie : état de l’art et perspectives pratiques
Autor: Cabaillé, M., Khalifa, J., Tessier, A.M., Belhomme, S., Créhange, G., Sargos, P.
Publikováno v: In Cancer / Radiothérapie May 2021 25(3):271-278
Zobrazit plný text záznamu
3
Akademický článek
Evaluation of Ethos intelligent optimization engine for left locally advanced breast cancer.
Autor: Prunaretty J; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France., Lopez L; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France., Cabaillé M; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France., Bourgier C; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France., Morel A; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France., Azria D; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France., Fenoglietto P; Radiotherapy Department, Montpellier Regional Cancer Institute, Montpellier, France.
Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jul 01; Vol. 14, pp. 1399978. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors.
Autor: Bordeau K; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Michalet M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Dorion V; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Keskes A; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Valdenaire S; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Debuire P; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Cantaloube M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Cabaillé M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Draghici R; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Ychou M; Medical oncology department, ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Assenat E; Medical oncology department, CHU St Eloi 34000, Montpellier, France., Jarlier M; Biometrics Unit ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Gourgou S; Biometrics Unit ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Guiu B; Radiology department, CHU St Eloi 34000, Montpellier, France., Ursic-Bedoya J; Liver Transplantation Unit, Department of Hepatology, Montpellier University Hospital, University of Montpellier, 34295, Montpellier, France., Aillères N; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Fenoglietto P; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Azria D; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Riou O; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France. Electronic address: olivier.riou@icm.unicancer.fr.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Dec; Vol. 189, pp. 109912. Date of Electronic Publication: 2023 Sep 20.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study.
Autor: Bordeau K; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Michalet M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Jacot W; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Demontoy S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Quantin X; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Ychou M; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Assenat E; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Mazard T; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Gauthier L; Biometrics Unit, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Dupuy M; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Guiu B; Radiology Department, CHU St. Eloi, 34000 Montpellier, France., Bourgier C; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Aillères N; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Fenoglietto P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Feb 02; Vol. 12 (3). Date of Electronic Publication: 2023 Feb 02.
Zobrazit plný text záznamu
8
Akademický článek
Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.
Autor: Michalet M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Bettaïeb O; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Khalfi S; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Ghorbel A; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Aillères N; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., De Méric De Bellefon M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Charissoux M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Boisselier P; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Demontoy S; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Marguerit A; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Bouhafa T; CHU Hassan II, Radiotherapy and Brachyterapy, 30050 Fez, Morocco., Farcy-Jacquet MP; Institut de Cancérologie du Gard, University Federation of Radiation Oncology of Mediterranean Occitanie, CHU Carémeau, 30900 Nîmes, France., Fenoglietto P; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Dec 30; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 30.
Zobrazit plný text záznamu
9
Akademický článek
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study.
Autor: Bordeau K; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Michalet M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Portales F; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Ychou M; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Assenat E; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Mazard T; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Samalin E; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Gauthier L; Biometrics Unit, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Colombo PE; Digestive Surgery Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Carrere S; Digestive Surgery Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Souche FR; Surgical Department, CHU St. Eloi, 34000 Montpellier, France., Aillères N; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Fenoglietto P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Cancers [Cancers (Basel)] 2022 Dec 20; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 20.
Zobrazit plný text záznamu
10
Akademický článek
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.
Autor: Khalifa J; Department of Radiotherapy, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole, France., Supiot S; Department of Radiotherapy, Institut de Cancérologie de l'Ouest, Nantes Saint-Herblain, France., Pignot G; Department of Urology, Institut Paoli Calmettes, Marseille, France., Hennequin C; Department of Radiotherapy, Hôpital Saint Louis, Paris, France., Blanchard P; Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France., Pasquier D; Department of Radiotherapy, Centre Oscar Lambret, Lille, France., Magné N; Department of Radiotherapy, Institut de Cancérologie Lucien Neuwirth, Saint Priest en Jarez, France., de Crevoisier R; Department of Radiotherapy, Centre Eugène Marquis, Rennes, France., Graff-Cailleaud P; Department of Radiotherapy, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole, France., Riou O; Department of Radiotherapy, Institut du Cancer de Montpellier, France., Cabaillé M; Department of Radiotherapy, Institut Bergonié, Bordeaux, France., Azria D; Department of Radiotherapy, Institut du Cancer de Montpellier, France., Latorzeff I; Department of Radiotherapy, Clinique Pasteur, Toulouse, France., Créhange G; Department of Radiotherapy, Institut Curie, Paris, France., Chapet O; Department of Radiotherapy, Hospices Civils de Lyon, France., Rouprêt M; Department of Urology, Hôpital Pitié-Salpétrière, APHP Sorbonne Université, Paris, France., Belhomme S; Department of Medical Physics, Institut Bergonié, Bordeaux, France., Mejean A; Department of Urology, Hôpital Européen Georges-Pompidou, Paris, France., Culine S; Department of Medical Oncology, Hôpital Saint-Louis, Paris, France., Sargos P; Department of Radiotherapy, Institut Bergonié, Bordeaux, France. Electronic address: p.sargos@bordeaux.unicancer.fr.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Aug; Vol. 161, pp. 95-114. Date of Electronic Publication: 2021 Jun 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje